Ignite Creation Date:
2025-12-25 @ 12:56 AM
Ignite Modification Date:
2025-12-25 @ 11:11 PM
Study NCT ID:
NCT06214793
Status:
SUSPENDED
Last Update Posted:
2025-05-01
First Post:
2024-01-10
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC)
Sponsor:
Megan Kruse, MD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-04
Start Date Type:
ESTIMATED
Primary Completion Date:
2030-01-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-10
First Submit QC Date:
None
Study First Post Date:
2024-01-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-30
Last Update Post Date:
2025-05-01
Last Update Post Date Type:
ACTUAL